Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
39
BBIO
BridgeBio Pharma
Last Price:
26.81
Seasonality Move:
21.04%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- The current trend is relatively stagnant and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.59 | Sell |
20-day SMA: | 27.31 | Sell |
50-day SMA: | 26.49 | Sell |
200-day SMA: | 30.04 | Sell |
8-day EMA: | 27.11 | Sell |
20-day EMA: | 27.18 | Sell |
50-day EMA: | 26.81 | Sell |
200-day EMA: | 27.48 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 44.56 | Sell |
Chaikin Money Flow: | -1012647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.61 - 29.05) | Sell |
Bollinger Bands (100): | (25.05 - 28.77) | Sell |
BridgeBio Pharma Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 25.96 while BBIO 8-day simple moving average is 27.59, which is a Sell signal.
- The stock price of BBIO is 25.96 while BridgeBio Pharma 20-day SMA is 27.31, which makes it a Sell.
- BridgeBio Pharma 50-day simple moving average is 26.49 while BBIO share price is 25.96, making it a Sell technically.
- BBIO stock price is 25.96 and BridgeBio Pharma 200-day simple moving average is 30.04, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $25.96. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
4.88B
Price in USD:
25.96
Share Volume:
1.47M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
21.62
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 25.96 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 25.96 while BBIO 8-day exponential moving average is 27.11, which is a Sell signal.
- The stock price of BBIO is 25.96 while BridgeBio Pharma 20-day EMA is 27.18, which makes it a Sell.
- BridgeBio Pharma 50-day exponential moving average is 26.81 while BBIO share price is 25.96, making it a Sell technically.
- BBIO stock price is 25.96 and BridgeBio Pharma 200-day simple moving average is 27.48, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $1.24 per share, and a decrease next year of $1.28 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting BridgeBio Pharma is a Buy
- BridgeBio Pharma Relative Strength Index (RSI) is 44.56, which suggest BridgeBio Pharma is oversold
- The Bollinger Bands (25) for BridgeBio Pharma is (24.61 - 29.05), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (25.05 - 28.77), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.